ndiye nawu Mndandanda wamakampani apamwamba a Biotech ku Germany omwe amasanjidwa potengera ndalama zonse.
S / N | Dzina Lakampani | Ndalama Zonse (FY) | Chiwerengero cha antchito |
1 | Morphosys Ag | $ Miliyoni 401 | 615 |
2 | Brain Biotec Na | $ Miliyoni 45 | 279 |
3 | Formycon Ag | $ Miliyoni 42 | 131 |
4 | Biofrontera Ag Na | $ Miliyoni 37 | 149 |
5 | Vita 34 Ag Na | $ Miliyoni 25 | 116 |
6 | Malingaliro a kampani Heidelberg Pharma Ag | $ Miliyoni 10 | 84 |
7 | Medigene Ag Na | $ Miliyoni 10 | 121 |
8 | 4Sc Ag Inh. | $ Miliyoni 3 | 48 |
Morphosys Ag
MorphoSys AG amagulitsidwa pamasamba osiyanasiyana ogulitsa. Kampaniyo imayang'ana kwambiri zakupeza, chitukuko, ndikupereka mankhwala a khansa. MorphoSys imathandizira makasitomala padziko lonse lapansi.
Malingaliro a kampani BRAIN Biotech AG
BRAIN Biotech AG ndi kampani yaukadaulo, yomwe imagwira ntchito yopanga ndi malonda a bioactives, mankhwala achilengedwe, ndi ma enzymes eni ake. Imagwira ntchito m'magawo a BioScience ndi BioIndustrial.
Gawo la BioScience limagwira ntchito pa ma enzymes ndi ma microorganisms ogwira ntchito; ndipo amagwirizana ndi ogwira nawo ntchito m'mafakitale. Gawo la BioIndustrial limachita ndi mabizinesi a bioproduct ndi zodzoladzola. Kampaniyo idakhazikitsidwa ndi Holger Zinke, Jüngen Eck, ndi Hans Günter Gassen pa Seputembara 22, 1993 ndipo likulu lake lili ku Zwingenberg, Germany.
Formycon
Formycon ndiwotsogola, wodziyimira pawokha wamankhwala apamwamba kwambiri a biopharmaceutical, makamaka biosimilars. Kampaniyo imayang'ana kwambiri zachipatala cha ophthalmology, immunology ndi matenda ena owopsa, omwe amakhudza zonse zamtengo wapatali kuyambira chitukuko chaukadaulo mpaka gawo lachitatu lachipatala komanso kukonza ma dossiers kuti avomereze malonda.
Ndi ma biosimilars, Formycon ikuthandizira kwambiri popereka odwala ambiri momwe angathere kupeza mankhwala ofunikira komanso otsika mtengo. Formycon pakadali pano ili ndi ma biosimilars asanu ndi limodzi pakukula. Kutengera chidziwitso chake chambiri pakupanga mankhwala a biopharmaceutical, kampaniyo ikugwiranso ntchito yopanga mankhwala a COVID-19 FYB207.
Biofrontera Ag Na
Biofrontera AG ndi kampani ya biopharmaceutical yomwe imagwira ntchito bwino pakupanga ndi kugulitsa mankhwala akhungu ndi zodzoladzola zamankhwala. Kampani yochokera ku Leverkusen imapanga ndikugulitsa zinthu zatsopano zochizira, kuteteza komanso kusamalira khungu.
Zopangira zake zazikulu ndi Ameluz®, mankhwala ochizira khansa yapakhungu yopanda melanoma ndi zoyambira zake. Ameluz® yakhala ikugulitsidwa ku EU kuyambira 2012 komanso ku USA kuyambira May 2016. Ku Ulaya, kampaniyo imagulitsanso mndandanda wa Belixos® dermocosmetic series, mankhwala apadera osamalira khungu lowonongeka. Biofrontera ndi amodzi mwa ochepa aku Germany kampani yopanga mankhwala kulandira chilolezo chapakati cha ku Ulaya ndi US cha mankhwala opangidwa m'nyumba. Gulu la Biofrontera linakhazikitsidwa mu 1997 ndipo lalembedwa pa Frankfurt Stock Exchange (Prime Standard).
Vita 34 Ag Na
Yakhazikitsidwa ku Leipzig mu 1997 ngati magazi oyamba a umbilical chingwe banki ku Ulaya, Vita 34 ndi katundu wathunthu wa cryo-preservation ndipo amapereka njira zothandizira kusonkhanitsa magazi, kukonzekera ndi kusungirako maselo amtundu wa umbilical chingwe magazi ndi minofu.
Maselo a stem ndiwofunika kwambiri pakuchiritsa ma cell. Amasungidwa amoyo pa kutentha pafupifupi madigiri 180 Celsius kuti athe kuwagwiritsa ntchito mkati mwa chithandizo chamankhwala, pakafunika. Makasitomala opitilira 230.000 ochokera ku Germany ndi mayiko ena 20 atsegula kale ma cell cell deposits ndi Vita 34, motero amapereka thanzi la ana awo.
Malingaliro a kampani Heidelberg Pharma Ag
Heidelberg Pharma AG ndi kampani ya biopharmaceutical yomwe ikugwira ntchito mu oncology. Kampaniyo ikuyang'ana kwambiri pakupanga ma Antibody Drug Conjugates (ADCs) pochiza matenda a oncological. Heidelberg Pharma otchedwa ATACs ndi ADCs kutengera luso la ATAC lomwe limagwiritsa ntchito Amanitin monga chogwiritsira ntchito. Njira yachilengedwe yogwirira ntchito ya poizoni wa Amanitin imayimira njira yatsopano yochizira.
Pulatifomu ya eniyi ikugwiritsidwa ntchito popanga ma ATAC ochizira a Kampani komanso magwirizano a anthu ena kuti apange anthu osiyanasiyana ofuna kusankhidwa a ATAC. Wotsogolera wotsogolera HDP-101 ndi BCMA-ATAC ya myeloma yambiri. Owonjezera omwe akuyembekezeredwa kuti apite patsogolo ndi HDP-102, CD37 ATAC ya Non-Hodgkin lymphoma ndi HDP-103, PSMA ATAC ya khansa ya prostate yolimbana ndi metastatic castration.
Kampaniyo komanso kampani yake yocheperapo ya Heidelberg Pharma Research GmbH ili ku Ladenburg pafupi ndi Heidelberg ku Germany. Inakhazikitsidwa mu September 1997 monga Wilex Biotechnology GmbH ku Munich ndipo idasinthidwa kukhala WILEX AG mu 2000. Dzina la Kampani linasinthidwa kukhala Heidelberg Pharma AG.
Wothandizira Heidelberg Pharma GmbH tsopano akutchedwa Heidelberg Pharma Research GmbH. Malingaliro a kampani Heidelberg Pharma AG pa Frankfurt Stock Exchange